Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Ampacet's AI system automatically corrects color variations in real time, improving quality and reducing waste in operations.
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Van Dyk Recycling Solutions uses vertical integration to tackle the global plastic waste crisis through advanced processing.
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
According to a senior police officer cited in the IE report, at least 32 data sets are being integrated into the Safe City ...
Corbin Olson Amid mounting regulatory pressure, evolving trade flows, and shifting brand commitment dynamics, the United ...
The trial featured a blend of 20% Exact POE, 1% DeltaMax® performance modifier, and Ravapura®, a compound incorporating 25% ...
Opinion
Explosive Research into the Creation of Bioweapons Unleashed in The Sleeper Agent by Adam Finnegan
Adam Finnegan, Author and ResearcherContact Adam Finnegan, [email protected] or 774.207.8039 [email protected] or C. Brylski (504) 460-1468 or [email protected] claims ...
KABUL (Pajhwok): A laboratory has been constructed and equipped with various advanced medical instruments, diagnostic materials, tables and chairs at a cost of 35 million afghanis at the Afghan ...
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results